CYTO
Altamira Therapeutics Ltd

25,446
Loading...
Loading...
News
all
press releases
Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024
Hamilton, Bermuda, April 04, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA...
Globe Newswire·1y ago
News Placeholder
More News
News Placeholder
Altamira Therapeutics enters collaboration with Univercells
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines
HAMILTON, BERMUDA, March 25, 2024 (GLOBE NEWSWIRE) -- Univercells to test proprietary mRNA vaccine delivered with Altamira's SemaPhore nanoparticlesTargeting safer and accessible mRNA vaccines...
Globe Newswire·2y ago
News Placeholder
Vivani Medical, Altamira Therapeutics, Quoin Pharmaceuticals among healthcare movers
Vivani Medical, Altamira Therapeutics, Quoin Pharmaceuticals among healthcare movers...
SeekingAlpha.com: All News·2y ago
News Placeholder
Altamira Therapeutics' Peptide-Based Delivery Platform Shown to Enhance Potency of Commonly Used Gene Delivery Method as Published in Peer-Reviewed Journal
HAMILTON, BERMUDA, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Independent peer-reviewed study shows enhanced cell transduction with adeno-associated virus (AAV) vectors, commonly used in gene therapy...
Globe Newswire·2y ago
News Placeholder
Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment
HAMILTON, BERMUDA, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Altamira's polyKRASmut siRNA shown to knock down at least 65-91% of KRAS mutations in colorectal, non-small cell lung, and pancreatic...
Globe Newswire·2y ago
News Placeholder
Altamira Therapeutics files to sell 162,548 shares of common stock
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit
HAMILTON, BERMUDA , Jan. 08, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit Altamira's two flagship programs, AM-401 and AM-411...
Globe Newswire·2y ago

Latest CYTO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.